Universal preoperative SARS-CoV-2 testing can facilitate safe surgical treatment during local COVID-19 surges
- PMID: 33640925
- PMCID: PMC7799208
- DOI: 10.1093/bjs/znaa062
Universal preoperative SARS-CoV-2 testing can facilitate safe surgical treatment during local COVID-19 surges
Abstract
This research letter details the experience of a large cancer center's experience with a universal asymptomatic preoperative SARS-CoV-2 testing program that facilitated safe surgical treatment during a local surge of coronavirus cases. A total of 5,234 asymptomatic tests were performed with a test positivity rate that correlated with the increase in community prevalence of COVID-19 infections. No patients developed a postoperative SARS-CoV-2 infection with no documented patient-to-patient or patient-to-provider spread.
Figures
References
-
- Texas Health and Human Services. Texas COVID-19 Data; 2020. https://www.dshs.texas.gov/coronavirus/additionaldata (accessed 20 September 2020)
-
- American College of Surgeons. COVID-19: Executive Orders by State on Dental, Medical, and Surgical Procedures; 2020. https://www.facs.org/covid-19/legislative-regulatory/executive-orders (accessed 20 September 2020)
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
